Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

NLSP Stock Forecast, Price Targets, Chart, Dividends & Analysis

NLS Pharmaceutics Ltd logo

NLS Pharmaceutics Ltd

Sector: Manufacturing   

Industry: Pharmaceutical Preparation Manufacturing

1.95
 
USD
  
-0.43
  
(-18.07%)
Previous close: 2.38  Open: 2.23  Bid: 1.9  Ask: 1.99
52 week range    
1.73   
   24.32
Mkt Cap: 2 M  Avg Vol (90 Days): 399,611
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

23
Technical
28
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

NLSP Income Statement

Annual
Invalid dateDec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-1.0-0.32
Basic EPS total-1.0-0.84-0.32
Basic weighted shares outstanding7 M12 M20 M38 M
Diluted EPS total-1.0-0.84-0.32
Diluted normalized net income/share-0.32
Diluted weighted shares outstanding7 M12 M20 M38 M
GeneralAndAdministrativeExpense2 M6 M7 M6 M
Gross operating profit2 M16 M
Income before tax-3 M-12 M-15 M-12 M
Income taxes-384301.0-1 M-1 M
InterestExpenseNonOperating233700.068134.0100866.0145153.0
InterestExpenseOperating-24100.0-732.0-2743.0
MiscOtherSpecialCharges-328365.0-17323.010045.0-219812.0
Net income from total operations-3 M-12 M-16 M-12 M
NetIncomeCommonStockholders-3 M-12 M-16 M-12 M
NetIncomeContinuousOperations-3 M-12 M-16 M-12 M
NetIncomeFromOtherGainsLosses-922495.0
NetNonOperatingInterestIncomeExpense-233700.0-68134.0-100866.0-145153.0
NonRecurringOperationExpense132358.0
Normalized income-9 M
Operating income-2 M-12 M-15 M-12 M
Operating income before depreciation (EBITDA)-3 M-12 M-15 M-12 M
OperatingExpense2 M12 M-15 M12 M
Other income net329048.017323.0-110993.0219812.0
Other special charges132358.0
OtherGandA2 M6 M7 M6 M
OtherImpairmentOfCapitalAssets683.0
OtherOperatingExpenses-2 M
RentAndLandingFees7 M
Research & development expense99580.06 M9 M6 M
ResearchExpense99580.06 M9 M
Revenue per share-48088.0
SalariesAndWages-12500.0
Selling Gen & administrative expense2 M6 M7 M6 M
SellingAndMarketingExpense-285859.0
Special income/charges-683.0-132358.0
Total Income available for interest expense (EBIT)-3 M-12 M-15 M-12 M
Total common shares outstanding7 M16 M32 M
Total net income-3 M-12 M-16 M-12 M
Total ordinary shares1 M1 M1 M1 M
Total revenues2 M16 M
TotalExpenses2 M12 M-15 M12 M
TotalRevenue2 M16 M
WriteDown683.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University